Nutrien Stock: Buy, Hold, or Sell in 2026?

With Nutrien shares climbing after a tough stretch, investors are now questioning whether this rally still has room to run or is nearing its limits.

| More on:
Key Points
  • Nutrien (TSX:NTR) bounced back strongly in 2025 after two tough years, raising fresh questions about how far the recovery can go.
  • NTR stock’s recent gains are backed by improving conditions in agriculture, but higher expectations now make the next move less obvious.
  • These factors could help investors decide whether Nutrien’s rebound still offers upside or calls for patience instead.

After falling for two consecutive years, shares of Nutrien (TSX:NTR) staged a sharp recovery in 2025, ending the year with strong 32% gains. And this rally seems to be continuing so far this year, as NTR stock has already risen 12.2% in January so far to currently trade at $95.02 per share with a market cap of nearly $46 billion.

But are these gains really sustainable, or has the market already priced in most of the good news? That is where many investors feel stuck right now. In this article, I’ll talk about Nutrien stock, what is driving its recent strength, how the business is performing today, and whether this rally makes the stock a buy, a hold, or a sell heading into 2026.

Woman works in garden

Source: Getty Images

A closer look at Nutrien’s recent rebound

If you don’t know it already, as one of the world’s largest providers of crop inputs, Nutrien focuses on supplying potash, nitrogen, and phosphate products to farmers across global markets. It also runs a large retail network that supports growers directly, giving it exposure across multiple parts of the agricultural supply chain.

From a market perspective, NTR stock has clearly regained a level of stability it lacked over the prior two years. At this market price, it also offers a 3.1% annualized dividend yield, which continues to appeal to income-focused investors looking for cash returns besides price recovery.

What is fueling this performance

A key driver in NTR stock’s recent recovery has been improving sentiment around agricultural demand and pricing conditions. After a challenging period marked by volatility in crop input prices, the market has started to respond to signs of more balanced supply and demand. That shift has helped ease pressure on the company’s margins and brought a more predictable outlook for its earnings.

Another factor supporting Nutrien stock has been its disciplined cost management and a focus on operational efficiency. Notably, investors have seemingly rewarded the company for navigating a tough cycle without overextending its balance sheet. Together, these fundamental factors have helped turn sentiment positive again, which explains why the stock has climbed steadily rather than spiking on some short-term news.

Recent financial trends and business progress

In the September 2025 quarter, Nutrien reported sales of about US$6 billion and net earnings attributable to shareholders of roughly US$464 million. That marked a clear improvement from weaker periods earlier in the cycle, even as results continued to reflect normal swings across fertilizer markets.

For the first nine months of the year, the company’s net earnings reached about US$1.7 billion, showing stable performance compared with the prior year. Meanwhile, its cash generation remained solid, supporting Nutrien’s dividend payments and ongoing investment across the business.

How long-term initiatives shape Nutrien’s 2026 outlook

Nutrien continues to invest in optimizing production assets and strengthening its retail platform, both of which are likely to support its long-term competitiveness. These efforts also focus on improving its reliability, efficiency, and customer reach over time rather than chasing short-term volume growth.

That said, NTR stock’s strong rebound means investors’ expectations are now higher than they were a year ago. However, its future gains will continue to depend on real execution and stable market conditions rather than simple multiple expansion. That makes Nutrien look less like a growth stock and more like a stable dividend-paying stock with balanced upside potential in 2026.

Fool contributor Jitendra Parashar has no position in any of the stocks mentioned. The Motley Fool recommends Nutrien. The Motley Fool has a disclosure policy.

More on Dividend Stocks

dividends grow over time
Dividend Stocks

Top Canadian Stocks to Buy Right Now With $2,000

A $2,000 capital can buy top Canadian stocks right now and create a resilient machine.

Read more »

diversification and asset allocation are crucial investing concepts
Dividend Stocks

This Simple TFSA Plan Could Pay You Monthly in 2026

Transform your financial future by understanding how to achieve monthly passive income through strategic TFSA investments.

Read more »

Canadian dollars are printed
Dividend Stocks

Build a Cash-Gushing Passive-Income Portfolio With $14,000

The payouts of these TSX stocks function much like a regular paycheque, providing passive income to reinvest or to help…

Read more »

Dividend Stocks

3 Dividend Stocks That Could Help You Sleep Better in 2026

These three “sleep-better” dividend stocks rely on essential demand, giving you steadier cash flow when markets get noisy.

Read more »

customer adds cash to tip jar at business
Dividend Stocks

This TSX Stock Pays an 8.7% Dividend and Deposits Cash Monthly

Trading at a 25% discount to NAV, Firm Capital Property Trust (TSX:FCD.UN) currently offers a massive 8.7% monthly yield. Could…

Read more »

Man holds Canadian dollars in differing amounts
Dividend Stocks

This 4.6% Dividend Stock Is My Top Pick for Immediate Income

Lundin Gold just posted record free cash flow, a 4.6% dividend yield, and +50% margins. Here's why it's our top…

Read more »

Young adult concentrates on laptop screen
Dividend Stocks

What’s Going On With BCE’s Dividend?

BCE Inc (TSX:BCE) cut its dividend by more than half last year. What's happening now?

Read more »

dividends can compound over time
Dividend Stocks

This Canadian Dividend Stock Is Down 10% and Worth Holding Forever

There's much to like about Manulife stock at a reasonable valuation and a nice and growing dividend.

Read more »